24 Results for "

TGFβRI

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "TGFβRI" in MCE Product Catalog:

Cat. No.: HY-146780
CAS No.: 2421135-03-5
Target:  

TGF-β Receptor

Research Areas:  

Cancer

TGFβRI-IN-4 is a highly potent and orally active TGFβ receptor type I (TGFβRI) inhibitor, with IC50s of 44 nM and 42.5 nM for ALK5 and NIH3T3. TGFβRI-IN-4 can suppress tumor growth and tumor weight in tumor xenograft model .
loading...
    loading...
Cat. No.: HY-13227R
CAS No.: 627536-09-8
Target:  

TGF-β Receptor

Research Areas:  

Cancer

SD-208 (Standard) is the analytical standard of SD-208. This product is intended for research and analytical applications. SD-208 is a selective TGF-βRI (ALK5) inhibitor with IC50 of 48 nM, and > 100-fold selectivity over TGF-βRII.
loading...
    loading...
Cat. No.: HY-N17639
CAS No.: 2059921-60-5
Regiafuran C is a compound with both TGF-βRI inhibitory and anti-fibrotic activities. Regiafuran C effectively inhibits renal fibrosis by binding to TGF-βRI and interfering with the TGF-β/Smad and Wnt/β-catenin signaling pathways. Regiafuran C also exhibits free radical scavenging activity, but shows no anti-inflammatory activity in PGE2 competitive enzyme immunoassays. The ability of Regiafuran C to specifically block the Smad3-TGF-βRII interaction and inhibit fibrotic processes allows its use in renal fibrosis research .
loading...
    loading...
Cat. No.: HY-13227G
CAS No.: 627536-09-8
SD-208 (GMP) is SD-208 (HY-13227) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. SD-208 is a selective TGF-βRI (ALK5) inhibitor with IC50 of 48 nM, and > 100-fold selectivity over TGF-βRII.
loading...
    loading...